Author Question: If a physician disagrees with a concurrent review and keeps the patient in the hospital longer, what ... (Read 86 times)

olgavictoria

  • Hero Member
  • *****
  • Posts: 528
If a physician disagrees with a concurrent review and keeps the patient in the hospital longer, what is likely to happen with the insurance company?
 
  a. The physician will be removed from participation in the insurance program.
  b. The patient may be liable to pay out of pocket for the uncertified days.
  c. The insurance company will have to reconsider their opinion.
  d. The hospital will get involved to make sure the physician is paid.

Question 2

When a concurrent review determines that the patient no longer requires services, who determines when the patient will be discharged?
 
  a. The physician
  b. The plan administrator
  c. The patient
  d. The discharge planner



gasdhashg

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

Answer: b

Answer to Question 2

Answer: a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

For a complete list of videos, visit our video library